ReP USP - Resultado da busca

Artigo de periodico
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock (2024)
Sanchez-Pinto, L Nelson; Bennett, Tellen D; DeWitt, Peter E; Souza, Daniela Carla de
Fonte: JAMA. Unidade: HU
Assuntos: CRIANÇAS, MORTALIDADE HOSPITALAR, FALÊNCIA MÚLTIPLA DOS ÓRGÃOS, SEPSE, CHOQUE SÉPTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHEZ-PINTO, L Nelson et al. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA, v. 331, n. 8, p. 675-686, 2024Tradução . . Disponível em: https://repositorio.usp.br/directbitstream/1611c21d-2c0b-4412-9ee7-53094bb4ada1/3214302.pdf. Acesso em: 09 nov. 2024.
APA
Sanchez-Pinto, L. N., Bennett, T. D., DeWitt, P. E., & Souza, D. C. de. (2024). Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA, 331( 8), 675-686. doi:10.1001/jama.2024.0196
NLM
Sanchez-Pinto LN, Bennett TD, DeWitt PE, Souza DC de. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock [Internet]. JAMA. 2024 ; 331( 8): 675-686.[citado 2024 nov. 09 ] Available from: https://repositorio.usp.br/directbitstream/1611c21d-2c0b-4412-9ee7-53094bb4ada1/3214302.pdf
Vancouver
Sanchez-Pinto LN, Bennett TD, DeWitt PE, Souza DC de. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock [Internet]. JAMA. 2024 ; 331( 8): 675-686.[citado 2024 nov. 09 ] Available from: https://repositorio.usp.br/directbitstream/1611c21d-2c0b-4412-9ee7-53094bb4ada1/3214302.pdf
Artigo de periodico
International Consensus Criteria for Pediatric Sepsis and Septic Shock (2024)
Schlapbach, Luregn J; Watson, R Scott; Sorce, Lauren R; Souza, Daniela Carla de
Fonte: JAMA. Unidade: HU
Assuntos: CRIANÇAS, CONSENSO, FALÊNCIA MÚLTIPLA DOS ÓRGÃOS, SEPSE, CHOQUE SÉPTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHLAPBACH, Luregn J et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA, v. 331, n. 8, p. 665-674, 2024Tradução . . Disponível em: https://repositorio.usp.br/directbitstream/c60a38f7-2c9e-444a-8f84-e2bd79a07767/3214300.pdf. Acesso em: 09 nov. 2024.
APA
Schlapbach, L. J., Watson, R. S., Sorce, L. R., & Souza, D. C. de. (2024). International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA, 331( 8), 665-674. doi:10.1001/jama.2024.0179
NLM
Schlapbach LJ, Watson RS, Sorce LR, Souza DC de. International Consensus Criteria for Pediatric Sepsis and Septic Shock [Internet]. JAMA. 2024 ; 331( 8): 665-674.[citado 2024 nov. 09 ] Available from: https://repositorio.usp.br/directbitstream/c60a38f7-2c9e-444a-8f84-e2bd79a07767/3214300.pdf
Vancouver
Schlapbach LJ, Watson RS, Sorce LR, Souza DC de. International Consensus Criteria for Pediatric Sepsis and Septic Shock [Internet]. JAMA. 2024 ; 331( 8): 665-674.[citado 2024 nov. 09 ] Available from: https://repositorio.usp.br/directbitstream/c60a38f7-2c9e-444a-8f84-e2bd79a07767/3214300.pdf
Artigo de periodico
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome (2017)
Cavalcanti, Alexandre Biasi; Suzumura, Érica Aranha; Laranjeira, Ligia Nasi; Paisani, Denise de Moraes; Damiani, Lucas Petri; Guimarães, Helio Penna; Romano, Edson Renato; Regenga, Marisa de Moraes; Taniguchi, Luzia Noriko Takahashi; Teixeira, Cassiano; Machado, Flavia Ribeiro; Diaz Quijano, Fredi Alexander; Filho, Meton Soares de Alencar; Maia, Israel Silva; Caser, Eliana Bernardete; Filho, Wilson de Oliveira; Borges, Marcos de Carvalho; Martins, Priscilla de Aquino; Matsui, Mirna; Ospina-Tascón, Gustavo Adolfo; Giraldo-Ramirez, Nelson Dario; Vieira, Silvia Regina Rios; Assef, Maria da Graça Pasquotto de Lima; Hasan, Mohd Shahnaz; Szczeklik, Wojciech; Rios, Fernando; Amato, Marcelo Britto Passos; Berwanger, Otávio; Carvalho, Carlos Roberto Ribeiro De
Fonte: JAMA. Unidade: FSP
Assuntos: DOENÇAS RESPIRATÓRIAS, UNIDADES DE TERAPIA INTENSIVA, MORTALIDADE, BAROTRAUMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTI, Alexandre Biasi et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome. JAMA, v. 318, n. 14, p. , 2017Tradução . . Disponível em: https://doi.org/10.1001/jama.2017.14171. Acesso em: 09 nov. 2024.
APA
Cavalcanti, A. B., Suzumura, É. A., Laranjeira, L. N., Paisani, D. de M., Damiani, L. P., Guimarães, H. P., et al. (2017). Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome. JAMA, 318( 14), . doi:10.1001/jama.2017.14171
NLM
Cavalcanti AB, Suzumura ÉA, Laranjeira LN, Paisani D de M, Damiani LP, Guimarães HP, Romano ER, Regenga M de M, Taniguchi LNT, Teixeira C, Machado FR, Diaz Quijano FA, Filho MS de A, Maia IS, Caser EB, Filho W de O, Borges M de C, Martins P de A, Matsui M, Ospina-Tascón GA, Giraldo-Ramirez ND, Vieira SRR, Assef M da GP de L, Hasan MS, Szczeklik W, Rios F, Amato MBP, Berwanger O, Carvalho CRRD. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome [Internet]. JAMA. 2017 ;318( 14): .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2017.14171
Vancouver
Cavalcanti AB, Suzumura ÉA, Laranjeira LN, Paisani D de M, Damiani LP, Guimarães HP, Romano ER, Regenga M de M, Taniguchi LNT, Teixeira C, Machado FR, Diaz Quijano FA, Filho MS de A, Maia IS, Caser EB, Filho W de O, Borges M de C, Martins P de A, Matsui M, Ospina-Tascón GA, Giraldo-Ramirez ND, Vieira SRR, Assef M da GP de L, Hasan MS, Szczeklik W, Rios F, Amato MBP, Berwanger O, Carvalho CRRD. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome [Internet]. JAMA. 2017 ;318( 14): .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2017.14171
Artigo de periodico
Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial (2017)
Tucci, Mauro Roberto; Hajjar, Ludhmila Abrahão; Galas, Filomena Regina Barbosa Gomes; Borges, Marcos de Carvalho; Carvalho, Carlos Roberto Ribeiro de; Amato, Marcelo Britto Passos
Fonte: JAMA. Unidades: FM, FMRP
Assuntos: ESTUDOS RANDOMIZADOS, SÍNDROME DO DESCONFORTO RESPIRATÓRIO EM ADULTOS, MORTALIDADE, RESPIRAÇÃO ARTIFICIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TUCCI, Mauro Roberto et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA, v. 318, n. 14, p. 1335-1345, 2017Tradução . . Disponível em: https://doi.org/10.1001/jama.2017.14171. Acesso em: 09 nov. 2024.
APA
Tucci, M. R., Hajjar, L. A., Galas, F. R. B. G., Borges, M. de C., Carvalho, C. R. R. de, & Amato, M. B. P. (2017). Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA, 318( 14), 1335-1345. doi:10.1001/jama.2017.14171
NLM
Tucci MR, Hajjar LA, Galas FRBG, Borges M de C, Carvalho CRR de, Amato MBP. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial [Internet]. JAMA. 2017 ; 318( 14): 1335-1345.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2017.14171
Vancouver
Tucci MR, Hajjar LA, Galas FRBG, Borges M de C, Carvalho CRR de, Amato MBP. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial [Internet]. JAMA. 2017 ; 318( 14): 1335-1345.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2017.14171
Artigo de periodico-carta/editorial
Alternatives in the evaluation of suspected coronary heart disease [letter] (2017)
Bittencourt, Márcio Sommer; Fernandes, Juliano Lara
Fonte: JAMA. Unidade: HU
Assunto: CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer e FERNANDES, Juliano Lara. Alternatives in the evaluation of suspected coronary heart disease [letter]. JAMA. Chicago: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1001/jama.2016.18323. Acesso em: 09 nov. 2024. , 2017
APA
Bittencourt, M. S., & Fernandes, J. L. (2017). Alternatives in the evaluation of suspected coronary heart disease [letter]. JAMA. Chicago: Hospital Universitário, Universidade de São Paulo. doi:10.1001/jama.2016.18323
NLM
Bittencourt MS, Fernandes JL. Alternatives in the evaluation of suspected coronary heart disease [letter] [Internet]. JAMA. 2017 ; 317( ja 2017): 211.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2016.18323
Vancouver
Bittencourt MS, Fernandes JL. Alternatives in the evaluation of suspected coronary heart disease [letter] [Internet]. JAMA. 2017 ; 317( ja 2017): 211.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1001/jama.2016.18323
Artigo de periodico
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis (2006)
Ataíde Junior, Luiz; Atie, Jacob; Avezum, Álvaro; Bandeira, Francisco; Bodanese, Luiz; Brasileiro, Antonio; Carvalho, Antonio Carlos; Esporcatte, Roberto; Esteves, José Péricles; Eugênio, Angela Maria; Feitosa, Gilson; Fernandes, Jefferson; Halpern, Alfredo; Lopes, Cícero; Lyra, Ruy; Machado, Nilton; Maciel, Léa Maria Zanini; Marino, Roberto; Massaro, Ayrton; Matos, Amélio; Mesquita, Evandro; Moreira, Maria; Nagato, Yosio; Nicolau, José Carlos; Nogueira, Paulo Roberto; Pazin-Filho, Antônio; Pires, Marco Tulio; Rocha, Antonio; Rocha, Ricardo; Saraiva, José Francisco; Schmid, Helena; Azul, João Serro; Tambascia, Marcos; Xavier, Sérgio; Yamamoto, Fabio; Yoshida, Winston; Zanella, Maria Tereza
Fonte: JAMA. Unidade: FMRP
Assuntos: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ATAÍDE JUNIOR, Luiz et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, v. 295, n. 2, p. 180-189, 2006Tradução . . Acesso em: 09 nov. 2024.
APA
Ataíde Junior, L., Atie, J., Avezum, Á., Bandeira, F., Bodanese, L., Brasileiro, A., et al. (2006). International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 295( 2), 180-189.
NLM
Ataíde Junior L, Atie J, Avezum Á, Bandeira F, Bodanese L, Brasileiro A, Carvalho AC, Esporcatte R, Esteves JP, Eugênio AM, Feitosa G, Fernandes J, Halpern A, Lopes C, Lyra R, Machado N, Maciel LMZ, Marino R, Massaro A, Matos A, Mesquita E, Moreira M, Nagato Y, Nicolau JC, Nogueira PR, Pazin-Filho A, Pires MT, Rocha A, Rocha R, Saraiva JF, Schmid H, Azul JS, Tambascia M, Xavier S, Yamamoto F, Yoshida W, Zanella MT. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295( 2): 180-189.[citado 2024 nov. 09 ]
Vancouver
Ataíde Junior L, Atie J, Avezum Á, Bandeira F, Bodanese L, Brasileiro A, Carvalho AC, Esporcatte R, Esteves JP, Eugênio AM, Feitosa G, Fernandes J, Halpern A, Lopes C, Lyra R, Machado N, Maciel LMZ, Marino R, Massaro A, Matos A, Mesquita E, Moreira M, Nagato Y, Nicolau JC, Nogueira PR, Pazin-Filho A, Pires MT, Rocha A, Rocha R, Saraiva JF, Schmid H, Azul JS, Tambascia M, Xavier S, Yamamoto F, Yoshida W, Zanella MT. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295( 2): 180-189.[citado 2024 nov. 09 ]
Artigo de periodico
Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview (2004)
Petersen, John L.; Mahaffey, Kenneth W.; Hasselblad, Vic; Antman, Elliott M.; Cohen, Marc; Goodman, Shaun G.; Langer, Anatoly; Blazing, Michael A.; Le-Moigne-Amrani, Anne; Lemos, James A. de; Nessel, Christopher C.; Harrington, Robert A.; Ferguson, James J.; Braunwald, Eugene; Califf, Robert M.; Marin-Neto, José Antônio
Fonte: JAMA. Unidade: FMRP
Assunto: INFARTO DO MIOCÁRDIO (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETERSEN, John L. et al. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, v. 292, n. 1, p. 89-96, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.accreview.2004.08.090. Acesso em: 09 nov. 2024.
APA
Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., et al. (2004). Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, 292( 1), 89-96. doi:10.1016/j.accreview.2004.08.090
NLM
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090
Vancouver
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090
Artigo de periodico
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial (2004)
Lemos, James A.; Blazing, Michael A.; Wiviott, Stephen D.; Lewis, Eldrin F.; Fox, Keith A. A.; White, Harvey D.; Rouleau, Jean-Lucien; Pedersen, Terje; Gardner, Laura H.; Mukherjee, Robin; Ramsey, Karen E.; Palmisano, Joanne; Bilheimer, David W.; Pfeffer, Marc A.; Califf, Robert M.; Braunwald, Eugene; Marin-Neto, José Antônio
Fonte: JAMA. Unidade: FMRP
Assunto: CORONARIOPATIA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEMOS, James A. et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA, v. 292, n. 11, p. 1307-1316, 2004Tradução . . Acesso em: 09 nov. 2024.
APA
Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A. A., White, H. D., et al. (2004). Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA, 292( 11), 1307-1316.
NLM
Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KAA, White HD, Rouleau J-L, Pedersen T, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E, Marin-Neto JA. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA. 2004 ; 292( 11): 1307-1316.[citado 2024 nov. 09 ]
Vancouver
Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KAA, White HD, Rouleau J-L, Pedersen T, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E, Marin-Neto JA. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA. 2004 ; 292( 11): 1307-1316.[citado 2024 nov. 09 ]
Artigo de periodico
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial (2004)
Marin-Neto, José Antônio
Fonte: JAMA. Unidade: FMRP
Assunto: CORONARIOPATIA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA, v. 292, n. 1, p. 45-54, 2004Tradução . . Acesso em: 09 nov. 2024.
APA
Marin-Neto, J. A. (2004). Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA, 292( 1), 45-54.
NLM
Marin-Neto JA. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA. 2004 ; 292( 1): 45-54.[citado 2024 nov. 09 ]
Vancouver
Marin-Neto JA. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA. 2004 ; 292( 1): 45-54.[citado 2024 nov. 09 ]
Artigo de periodico
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial (2004)
Blazing, Michael A.; Lemos, James A. de; White, Harvey; Fox, Keith A. A.; Verheugt, Freek W. A.; Ardissino, Diego; DiBattiste, Peter M.; Palmisano, Joanne; Bilheimer, David W.; Snapinn, Steven M.; Ramsey, Karen E.; Gardner, Laura H.; Hasselblad, Vic; Pfeffer, Marc A.; Lewis, Eldrin F.; Braunwald, Eugene; Califf, Robert M.; Marin-Neto, José Antônio
Fonte: JAMA. Unidade: FMRP
Assuntos: INFARTO DO MIOCÁRDIO (TRATAMENTO), ISQUEMIA MIOCÁRDICA (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLAZING, Michael A. et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA, 2004Tradução . . Acesso em: 09 nov. 2024.
APA
Blazing, M. A., Lemos, J. A. de, White, H., Fox, K. A. A., Verheugt, F. W. A., Ardissino, D., et al. (2004). Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA.
NLM
Blazing MA, Lemos JA de, White H, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM, Marin-Neto JA. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA. 2004 ;[citado 2024 nov. 09 ]
Vancouver
Blazing MA, Lemos JA de, White H, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM, Marin-Neto JA. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial. JAMA. 2004 ;[citado 2024 nov. 09 ]

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos